Feasibility Study Evaluating the Safety and Efficacy of the Renal Stimulation by Direct Wire Pacing, During Renal Denervation Procedure

Inclusion Criteria: * Patient willing and able to comply with the protocol and has provided written informed consent. * Age ≥18 * Patient candidate for renal denervation with the ParadiseTM System based on physician's assessment. * Patients affiliated to a social security system Exclusion Criteria: * Patients who meet any of the contraindications listed in the Instructions for Use of ParadiseTM Ultrasound Renal Denervation System will be excluded: * Renal arteries diameter \< 3 mm and \> 8 mm * Patient with relevant renal artery disease (% diameter stenosis \> 30%, aneurysm or fibromuscular disease) * Stented renal artery * Iliac/femoral artery stenosis precluding insertion of the ParadiseTM catheter * Known allergy to contrast medium * Patient with known secondary cause of hypertension * Patient with contraindication to chronic anticoagulation therapy or heparin * Patient with Type 1 diabetes mellitus * Patient with more than one accessory renal artery * Woman currently pregnant or breastfeeding * Patient with other concomitant conditions that may adversely affect the patient or the study outcome * Patient with mental or physical inability to participate in the study * Patient under judicial protection, tutorship, or curatorship